Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.

Shin YJ, Hyon JY, Choi WS, Yi K, Chung ES, Chung TY, Wee WR.

Invest Ophthalmol Vis Sci. 2013 Jul 2;54(7):4452-8. doi: 10.1167/iovs.13-11684.

PMID:
23716625
2.

Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.

Kwon YS, Hong HS, Kim JC, Shin JS, Son Y.

Invest Ophthalmol Vis Sci. 2005 Feb;46(2):454-60.

PMID:
15671269
3.
4.
5.

Minocycline inhibits alkali burn-induced corneal neovascularization in mice.

Xiao O, Xie ZL, Lin BW, Yin XF, Pi RB, Zhou SY.

PLoS One. 2012;7(7):e41858. doi: 10.1371/journal.pone.0041858. Epub 2012 Jul 25.

6.

Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.

Yang H, Li X, Ma J, Lv X, Zhao S, Lang W, Zhang Y.

Exp Eye Res. 2013 May;110:76-87. doi: 10.1016/j.exer.2013.02.015. Epub 2013 Mar 7.

PMID:
23482085
7.

Inhibitory effect of canstatin in alkali burn-induced corneal neovascularization.

Wang Y, Yin H, Chen P, Xie L, Wang Y.

Ophthalmic Res. 2011;46(2):66-72. doi: 10.1159/000322804. Epub 2011 Jan 14.

PMID:
21242701
8.

Alkali burn to the eye: protection using TNF-α inhibition.

Cade F, Paschalis EI, Regatieri CV, Vavvas DG, Dana R, Dohlman CH.

Cornea. 2014 Apr;33(4):382-9. doi: 10.1097/ICO.0000000000000071.

PMID:
24488127
9.

KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.

Zhou AY, Bai YJ, Zhao M, Yu WZ, Li XX.

Ophthalmic Res. 2013;50(3):180-6. doi: 10.1159/000353437. Epub 2013 Sep 4.

PMID:
24008241
10.

An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.

Uchiyama M, Shimizu A, Masuda Y, Nagasaka S, Fukuda Y, Takahashi H.

Mol Vis. 2013 Nov 1;19:2135-50. eCollection 2013.

11.

Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts.

Lee SH, Kim KW, Joo K, Kim JC.

BMC Ophthalmol. 2016 May 17;16:57. doi: 10.1186/s12886-016-0235-z.

12.

Pretreatment of rapamycin before allogenic corneal transplant promotes graft survival through increasing CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Wang X, Wang W, Xu J, Hong J, Le Q.

Exp Clin Transplant. 2013 Feb;11(1):56-62. doi: 10.6002/ect.2012.0025. Epub 2012 Jul 5.

13.

Comparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularization.

Jia C, Zhu W, Ren S, Xi H, Li S, Wang Y.

Mol Vis. 2011;17:2386-99. Epub 2011 Sep 2.

14.

Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury.

Yamada J, Dana MR, Sotozono C, Kinoshita S.

Exp Eye Res. 2003 Feb;76(2):161-7.

PMID:
12565803
15.

Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.

Wang X, Wang W, Xu J, Le Q.

Transplant Proc. 2013 Mar;45(2):528-37. doi: 10.1016/j.transproceed.2012.06.064. Epub 2012 Sep 13.

PMID:
23267787
16.

KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.

Li T, Hu A, Li S, Luo Y, Huang J, Yu H, Ma W, Pan J, Zhong Q, Yang J, Wu J, Tang S.

Mol Vis. 2011 Mar 25;17:797-803.

18.

NK1 receptor antagonists as a new treatment for corneal neovascularization.

Bignami F, Giacomini C, Lorusso A, Aramini A, Rama P, Ferrari G.

Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6783-94. doi: 10.1167/iovs.14-14553.

PMID:
25228541
19.

Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice.

Zhu J, Liu Y, Pi Y, Jia L, Wang L, Huang Y.

Acta Ophthalmol. 2014 Feb;92(1):e12-21. doi: 10.1111/aos.12237. Epub 2013 Aug 3.

20.

Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.

Zhang Z, Ma JX, Gao G, Li C, Luo L, Zhang M, Yang W, Jiang A, Kuang W, Xu L, Chen J, Liu Z.

Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4062-71.

PMID:
16249481

Supplemental Content

Support Center